Enzene has invested in technologies of the future to allow fully integrated development, beginning with cell line engineering to drug product development. We have the state-of-the-art analytical lab for comprehensive characterization of mAbs, high throughput screening technologies in our upstream as well as downstream process development. We have a proprietary cloning platform and internal regulatory science, which caters to most of the filing requirements.
read moreEnzene has end-to-end capabilities for solid-state as well as liquid-state manufacturing of custom peptide synthesis. We offer purification technologies for complex therapeutic peptides to ensure the highest level of purity and analytical technologies using UPLC, Mass spec to assure the most comprehensive characterization, and purity for customized peptide needs. We offer a comprehensive analytical testing package for peptides, which assures the highest purity standards.
read moreEnzene has revolutionized the field of continuous manufacturing by developing GMP processes which have disrupted the cost of manufacturing of mAbs and complex biologics. Our GMP compliant manufacturing facilities cater to mammalian based perfusion and fed-batch processes as well as a dedicated E. coli manufacturing unit. Our facilities are built as per the highest regulatory standards and inspected by several regulatory authorities. We offer flexible manufacturing that can meet all the production demands, both Bio Bulk which includes Microbial and Mammalian and Fill Finish lines which can support all the formats of parenteral products such as pre-filled syringes, cartridges, vials, and lyophilized products.
read moreEnzene has one of the strongest clinical and biosimilar pipelines in India. We have multiple products that are close to launching for the Indian market and the global market. And we are open to B2B opportunity for most of the region.
For more details connect to bd@enzene.com.
read more